We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00302016
Recruitment Status : No longer available
First Posted : March 13, 2006
Last Update Posted : August 26, 2011
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : No longer available
  Primary Completion Date : November 2008
  Study Completion Date : No date given